SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-001915
Filing Date
2015-05-14
Accepted
2015-05-14 07:05:18
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 535872
2 ex31-1.htm EX-31.1 17840
3 ex31-2.htm EX-31.2 17885
4 ex32-1.htm EX-32.1 6802
5 ex32-2.htm EX-32.2 6859
  Complete submission text file 0001493152-15-001915.txt   5220494

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20150331.xml EX-101.INS 659316
7 XBRL SCHEMA FILE aker-20150331.xsd EX-101.SCH 56687
8 XBRL CALCULATION FILE aker-20150331_cal.xml EX-101.CAL 66278
9 XBRL DEFINITION FILE aker-20150331_def.xml EX-101.DEF 168154
10 XBRL LABEL FILE aker-20150331_lab.xml EX-101.LAB 399728
11 XBRL PRESENTATION FILE aker-20150331_pre.xml EX-101.PRE 278733
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 15860237
SIC: 2835 In Vitro & In Vivo Diagnostic Substances